These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7477739)

  • 41. Effect of an endothelin-1 antagonist, BQ-485, on cerebral oxygen metabolism after complete global cerebral ischemia in dogs.
    Takasu A; Matsushima S; Takino M; Okada Y
    Resuscitation; 1997 Feb; 34(1):65-9. PubMed ID: 9051826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence endothelin ETA receptor antagonist--BQ-123--on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage.
    Jośko J; Hendryk S; Jedrzejowska-Szypuła H; Gwóźdź B; Herman ZS; Gawlik R
    J Physiol Pharmacol; 1998 Sep; 49(3):367-75. PubMed ID: 9789790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia.
    Patel TR; Galbraith S; Graham DI; Hallak H; Doherty AM; McCulloch J
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):950-8. PubMed ID: 8784239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog.
    Hirose H; Ide K; Sasaki T; Takahashi R; Kobayashi M; Ikemoto F; Yano M; Nishikibe M
    Eur J Pharmacol; 1995 Apr; 277(1):77-87. PubMed ID: 7635177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebrospinal fluid from patients with subarachnoid haemorrhage and vasospasm enhances endothelin contraction in rat cerebral arteries.
    Assenzio B; Martin EL; Stankevicius E; Civiletti F; Fontanella M; Boccaletti R; Berardino M; Mazzeo A; Ducati A; Simonsen U; Mascia L
    PLoS One; 2015; 10(1):e0116456. PubMed ID: 25629621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
    Vergouwen MD; Algra A; Rinkel GJ
    Stroke; 2012 Oct; 43(10):2671-6. PubMed ID: 22871682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelin-1-induced endothelin-1 release causes cerebral vasospasm in-vivo.
    Zuccarello M; Romano A; Passalacqua M; Rapoport RM
    J Pharm Pharmacol; 1995 Aug; 47(8):702. PubMed ID: 8583377
    [No Abstract]   [Full Text] [Related]  

  • 48. Novel receptor antagonists welcome a new era in endothelin biology.
    Douglas SA; Meek TD; Ohlstein EH
    Trends Pharmacol Sci; 1994 Sep; 15(9):313-6. PubMed ID: 7992380
    [No Abstract]   [Full Text] [Related]  

  • 49. Cerebrovascular endothelin receptor upregulation in cerebral ischemia.
    Edvinsson L
    Curr Vasc Pharmacol; 2009 Jan; 7(1):26-33. PubMed ID: 19149637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of endothelin in cardiovascular disease.
    Schiffrin EL; Intengan HD; Thibault G; Touyz RM
    Curr Opin Cardiol; 1997 Jul; 12(4):354-67. PubMed ID: 9263647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebral postischemic hypoperfusion is mediated by ETA receptors.
    Spatz M; Yasuma Y; Strasser A; McCarron RM
    Brain Res; 1996 Jul; 726(1-2):242-6. PubMed ID: 8836568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in rat.
    Barone FC; Ohlstein EH; Hunter AJ; Campbell CA; Hadingham SH; Parsons AA; Yang Y; Shohami E
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S357-61. PubMed ID: 11078420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular pharmacology and pathophysiological significance of endothelin.
    Goto K; Hama H; Kasuya Y
    Jpn J Pharmacol; 1996 Dec; 72(4):261-90. PubMed ID: 9015736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Future treatment of stroke. Brain damage in stroke can be reduced by drugs].
    Siesjö BK
    Lakartidningen; 1993 Sep; 90(36):2958, 2962-4. PubMed ID: 8366724
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of endothelinA-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm.
    Cosentino F; McMahon EG; Carter JS; Katusić ZS
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S332-5. PubMed ID: 7509979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
    Caner HH; Kwan AL; Arthur A; Jeng AY; Lappe RW; Kassell NF; Lee KS
    J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are selective endothelin A receptor antagonists better than mixed antagonists?
    Bagnall A; Webb D
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S43-6. PubMed ID: 11811376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydroxytryptamine 1B receptor upregulation through mitogen-activated protein kinase kinase 1/2 inhibition after subarachnoid hemorrhage in rats.
    Larsen CC; Povlsen GK; Rasmussen MN; Edvinsson L
    J Neurosurg; 2011 Apr; 114(4):1143-53. PubMed ID: 20597604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system.
    Doggrell SA
    Expert Opin Investig Drugs; 2002 Nov; 11(11):1537-52. PubMed ID: 12437501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelin: role in hypertension.
    Schiffrin EL
    Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.